Skip to content

Dr James Sun

Genetic changes in the bile ducts in PSC

Awarded to Dr James Sun, The Francis Crick Institute

 

The total grant awarded is £15,000

Duration of award: 09 months (February 2025 to October 2025)

Research title: Genetic changes in the bile ducts in PSC

Dr_James_Sun

Summary

PSC Support has awarded £15,000 to Dr James Sun to study how cells in bile ducts change in PSC. This project will be the first study to identify the genetic changes in bile duct cells in people with PSC. Dr Sun will explore the biological impact of these genetic changes using an artificially created bile duct, known as “organoids” – a way of growing cells in 3D in the laboratory.

This study is known as a “pilot study”, which means it is the very first investigation using state of the art technology that is designed to test whether, and how, a further, full study can be undertaken.

What will Dr Sun do?

In this pilot study Dr Sun will apply state of the art DNA sequencing technology to identify genetic changes in bile duct cells. He will separately develop a laboratory 3D cell model called organoids that will be used to study the biological effect of the genetic changes he identifies and determine how they alter the behaviour of bile duct cells.

Why is this study important?

This pilot study could provide us with a detailed understanding of the biological processes involved when bile duct cells become diseased. The aim is to develop a larger study with potential to benefit patients in two ways:

  1. Identify new drug targets in the cell changes discovered to delay or reverse progression of PSC
  2. Lead to the development of genetic tests that identify which patients are at higher risk of progression or cancer development in PSC

Progress Report

PSC patients undergoing camera tests and having transplants have been recruited into the study. The 3D model system that will be used to investigate the genetic changes has been set up. Work is ongoing to conduct DNA sequencing to detect the genetic changes. The team is deciding on the best technique to use to achieve meaningful results.

Dr James Sun, August 2025

Mission 2030 is an ambitious challenge and we can’t do it alone. We need your help to find the breakthrough people with PSC so desperately need.

It’s time we found effective treatments for PSC

Play your part in leaving no stone unturned

Donate now

Mission 2030 - Help us fund £1 million of research by 2030

Fundraise for research

We need your support now

more than ever!

Make a donation to research and all the other things we do to help people affected by PSC


More research we've funded:

DNA Methylation for Cancer Risk in PSC

Bile Duct Cancer Detection

Characterising Genetic Changes in Bile Ducts

Understanding Fatigue in PSC

Simvastatin in PSC

Biological Markers from Machine Learning

Predicting Bowel Cancer Risk

Understanding Pregnancy in PSC

Developing a blood test to predict and detect bile duct cancer

Validating a Diagnostic Biomarker in Primary Sclerosing Cholangitis

Cell States in the Transition from PSC to Bile Duct Cancer

PSC and IBD Link

Dr Palak Trivedi – FARGO

Dr Goode Dr Rushbrook Diagnostic Biomarker

Dr Banales Early Diagnosis of Bile Duct Cancer

UK-PSC Project Manager

Dr Boulter – Non-canonical Wnt Signalling

West Midlands Virtual PSC Programme

Dr Guest – Biomarkers in PSC/biliary duct cancer

Dr Williamson – PIP-C Study

We are your voice

Your views make that voice stronger. #LetsBeatPSC

Make a difference

Help us fund PSC research and support people with PSC

Want to know more?

Receive regular info, tips and news on all things PSC